143 related articles for article (PubMed ID: 14688017)
1. Ras gene mutations in patients with acute myeloid leukaemia and exposure to chemical agents.
Barletta E; Gorini G; Vineis P; Miligi L; Davico L; Mugnai G; Ciolli S; Leoni F; Bertini M; Matullo G; Costantini AS
Carcinogenesis; 2004 May; 25(5):749-55. PubMed ID: 14688017
[TBL] [Abstract][Full Text] [Related]
2. Parental exposure to medications and hydrocarbons and ras mutations in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Shu XO; Perentesis JP; Wen W; Buckley JD; Boyle E; Ross JA; Robison LL;
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1230-5. PubMed ID: 15247135
[TBL] [Abstract][Full Text] [Related]
3. Analysis of ras gene mutations in acute myeloid leukemia by the polymerase chain reaction and oligonucleotide probes.
Chin YM; Bosco JJ; Koh CL
Singapore Med J; 1992 Feb; 33(1):48-50. PubMed ID: 1598607
[TBL] [Abstract][Full Text] [Related]
4. Lifetime history of alcohol consumption and K-ras mutations in pancreatic ductal adenocarcinoma.
Crous-Bou M; Porta M; López T; Jariod M; Malats N; Morales E; Guarner L; Rifà J; Carrato A; Real FX;
Environ Mol Mutagen; 2009 Jun; 50(5):421-30. PubMed ID: 19326463
[TBL] [Abstract][Full Text] [Related]
5. ras gene activation in a minor proportion of the blast population in acute myeloid leukemia.
Toksoz D; Farr CJ; Marshall CJ
Oncogene; 1987; 1(4):409-13. PubMed ID: 3330783
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of N-RAS and K-RAS mutations in 232 patients with acute myeloid leukemia.
Ritter M; Kim TD; Lisske P; Thiede C; Schaich M; Neubauer A
Haematologica; 2004 Nov; 89(11):1397-9. PubMed ID: 15531466
[TBL] [Abstract][Full Text] [Related]
7. K-Ras mutations and N-Ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangements.
Liang DC; Shih LY; Fu JF; Li HY; Wang HI; Hung IJ; Yang CP; Jaing TH; Chen SH; Liu HC
Cancer; 2006 Feb; 106(4):950-6. PubMed ID: 16404744
[TBL] [Abstract][Full Text] [Related]
8. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
9. Frequency of RAS gene mutation and its cooperative genetic events in Southeast Asian adult acute myeloid leukemia.
Auewarakul CU; Lauhakirti D; Tocharoentanaphol C
Eur J Haematol; 2006 Jul; 77(1):51-6. PubMed ID: 16573741
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia: analysis of ras gene mutations and clonality defined by polymorphic X-linked loci.
Bartram CR; Ludwig WD; Hiddemann W; Lyons J; Buschle M; Ritter J; Harbott J; Fröhlich A; Janssen JW
Leukemia; 1989 Apr; 3(4):247-56. PubMed ID: 2564452
[TBL] [Abstract][Full Text] [Related]
11. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.
Shen S; Passioura T; Symonds G; Dolnikov A
Exp Hematol; 2007 Jun; 35(6):908-19. PubMed ID: 17533045
[TBL] [Abstract][Full Text] [Related]
12. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
13. Novel loss-of-function mutations of the haematopoiesis-related transcription factor, acute myeloid leukaemia 1/runt-related transcription factor 1, detected in acute myeloblastic leukaemia and myelodysplastic syndrome.
Nakao M; Horiike S; Fukushima-Nakase Y; Nishimura M; Fujita Y; Taniwaki M; Okuda T
Br J Haematol; 2004 Jun; 125(6):709-19. PubMed ID: 15180860
[TBL] [Abstract][Full Text] [Related]
14. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
[TBL] [Abstract][Full Text] [Related]
15. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
Bentires-Alj M; Paez JG; David FS; Keilhack H; Halmos B; Naoki K; Maris JM; Richardson A; Bardelli A; Sugarbaker DJ; Richards WG; Du J; Girard L; Minna JD; Loh ML; Fisher DE; Velculescu VE; Vogelstein B; Meyerson M; Sellers WR; Neel BG
Cancer Res; 2004 Dec; 64(24):8816-20. PubMed ID: 15604238
[TBL] [Abstract][Full Text] [Related]
16. ras oncogene activation and occupational exposures in acute myeloid leukemia.
Taylor JA; Sandler DP; Bloomfield CD; Shore DL; Ball ED; Neubauer A; McIntyre OR; Liu E
J Natl Cancer Inst; 1992 Nov; 84(21):1626-32. PubMed ID: 1433344
[TBL] [Abstract][Full Text] [Related]
17. Alcohol and the risk of colon and rectal cancer with mutations in the K-ras gene.
Bongaerts BW; de Goeij AF; van den Brandt PA; Weijenberg MP
Alcohol; 2006 Apr; 38(3):147-54. PubMed ID: 16905440
[TBL] [Abstract][Full Text] [Related]
18. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report.
Sameer AS; Chowdhri NA; Abdullah S; Shah ZA; Siddiqi MA
Indian J Cancer; 2009; 46(3):219-25. PubMed ID: 19574674
[TBL] [Abstract][Full Text] [Related]
19. Leukemic transformation in three patients with polycythemia vera. Analysis of the clinicopathological features and N-ras gene mutation.
Sakai H; Karasawa M; Okamoto K; Maehara T; Tsukamoto N; Murakami H; Naruse T; Morita K; Tsuchiya J
J Med; 1996; 27(3-4):183-91. PubMed ID: 8982966
[TBL] [Abstract][Full Text] [Related]
20. Farnesyltransferase inhibitors and their potential role in therapy for myelodysplastic syndromes and acute myeloid leukaemia.
Braun T; Fenaux P
Br J Haematol; 2008 May; 141(5):576-86. PubMed ID: 18410457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
